Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Reduced Brain-Derived Neurotrophic Factor (BDNF) levels have been described in a number of patho-physiological conditions, most notably, in Huntington's disease (HD), a progressive neurodegenerative disorder. Since BDNF is also produced in blood, we have undertaken the measurement of its peripheral levels in the attempt to identify a possible link with HD prognosis and/or its progression. Here we evaluated BDNF level in 398 blood samples including 138 controls, 56 preHD, and 204 HD subjects. We found that BDNF protein levels were not reliably different between groups, whether measured in plasma (52 controls, 26 preHD, 105 HD) or serum (39 controls, 5 preHD, 29 HD). Our experience, and a re-analysis of the literature highlighted that intra-group variability and methodological aspects affect this measurement, especially in serum. We also assessed BDNF mRNA levels in blood samples from 47 controls, 25 preHD, and 70 HD subjects, and found no differences among the groups. We concluded that levels of BDNF in human blood were not informative (mRNA levels or plasma protein level) nor reliable (serum protein levels) as HD biomarkers. We also wish to warn the scientific community in interpreting the significance of changes measured in BDNF protein levels in serum from patients suffering from different conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 mRNA levels of other HD-related genes in control and HD patients. Samples are from Italian Cohort C. Blood mRNA levels of (A) ANXA1 and (B) ROCK1 were measured with two different normalisation strategies (ß-actin mRNA levels (ß-ACT), according to [25], and EAR levels, according to [24].](https://figures.cochat.ai/paper-figures/0e1f7bacf29a461f9f513e18e813b527/brain-derived-neurotrophic-factor-in-patients-with-huntington-s-disease-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Key biomarkers include polyQ-Htt and Tau, which are detected in the CSF, as well as BDNF, which is measurable in the blood [253,254,255,256].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [256]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123 · cited 1×
“This is not due to the ELISA assay itself that has been extensively validated in cells, brain tissue and plasma samples [22,23,32].”
BackgroundSelf-citationBrain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947 · cited 4×
“We previously demonstrated that transcription from the BDNF promoters II, IV, and VI was reduced in the brains of HD animal models and in human postmortem brain tissue [10].”
BackgroundInfluentialSelf-citationThe impact of age, weight and gender on BDNF levels in human platelets and plasma
Lommatzsch, M., Zingler, D., Schuhbaeck, K., Schloetcke, K., Zingler, C., Schuff-Werner, P., & Virchow, J. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.002 · Cited by 842 · cited 3×
“, (2005) have shown that different types of blood collection tubes (EDTA or heparin-treated) can influence the BDNF content detected in plasma [17].”
BackgroundLangbehn, D., Brinkman, R., Falush, D., Paulsen, J., Hayden, M., & on behalf of an International Huntington's Disease Collaborative Group (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00241.x · Cited by 817 · cited 2×
“For each pre-HD individual, the estimated probability of onset within the next 5 years was calculated on the basis of the number of CAG repeats and his/her present age, according to Langbehn [19].”
MethodIndividuality and variation in gene expression patterns in human blood
Whitney, A. R., Diehn, M., Popper, S. J., Alizadeh, A. A., Boldrick, J. C., Relman, D. A., & Brown, P. O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252784499 · Cited by 778 · cited 1×
“Furthermore, microarray studies on blood samples from healthy subjects have shown intra-individual variation in the expression of several genes due to differences in the relative proportions of specific blood cell subsets, gender, age, and the time of day at which the blood was sampled [34].”
BackgroundBrain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation
Fujimura, H., Chen, R., Nakamura, T., Nakahashi, T., Kambayashi, J.-I., Sun, B., Altar, C., & Tandon, N. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613072 · Cited by 777
Blood BDNF Concentrations Reflect Brain-Tissue BDNF Levels across Species
Klein, A. B., Williamson, R., Santini, M. A., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G. M., & Aznar, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000738 · Cited by 726 · cited 1×
“BDNF has been detected also in the blood [6,7,8].”
BackgroundPruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699 · cited 1×
“The human BDNF gene is characterised by very complex regulation as it contains nine different promoters that act independently to modulate the transcription of BDNF mRNA in a stimulus- and time- specific manner [33].”
BackgroundRole of brain-derived neurotrophic factor in Huntington's disease
ZUCCATO, C., & CATTANEO, E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.003 · Cited by 552 · cited 5×
“The HD mutation did not affect BDNF mRNA in human peripheral blood A large number of in vitro and in vivo studies have shown that BDNF mRNA is consistently reduced in brain tissues from HD transgenic mice and patients [10,22].”
BackgroundInfluentialSelf-citationThe Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
Lee, B.-H., & Kim, Y.-K. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.4.231 · Cited by 445 · cited 1×
“affecting different organs [1,2,3,4,5].”
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease
Borovecki, F., Lovrecic, L., Zhou, J., Jeong, H., Then, F., Rosas, H. D., Hersch, S. M., Hogarth, P., Bouzou, B., Jensen, R. V., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504921102 · Cited by 414 · cited 5×
“We focused on the annexin A1 (ANXA1) and rho-associated protein kinase-1 (ROCK1) genes, because their expression was upregulated in HD blood and was sensitive to pharmacological treatment [25,26].”
BackgroundMethodResultInfluentialEffect of treatment on serum brain–derived neurotrophic factor levels in depressed patients
Gonul, A. S., Akdeniz, F., Taneli, F., Donat, O., Eker, Ç., & Vahip, S. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0578-6 · Cited by 375 · cited 1×
“Antidepressants were reported to increase BDNF levels in the serum of depressed subjects [21].”
BackgroundRadka, S. F., Hoist, P. A., Fritsche, M., & Altar, C. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01321-0 · Cited by 348 · cited 1×
“BDNF has been detected also in the blood [6,7,8].”
BackgroundDeterminants of serum brain-derived neurotrophic factor.
Bus, B. A. A., Molendijk, M. L., Penninx, B. J. W. H., Buitelaar, J. K., Kenis, G., Prickaerts, J., Elzinga, B. M., & Voshaar, R. C. O. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.013 · Cited by 279 · cited 2×
“However, intra-group variability may be problematic, especially since BDNF protein level is sensitive to a variety of factors [15,16,17,18].”
BackgroundTang, S. W., Chu, E., Hui, T., Helmeste, D., & Law, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.019 · Cited by 248 · cited 2×
“However, intra-group variability may be problematic, especially since BDNF protein level is sensitive to a variety of factors [15,16,17,18].”
BackgroundZuccato, C., Marullo, M., Conforti, P., MacDonald, M. E., Tartari, M., & Cattaneo, E. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00111.x · Cited by 231
Self-citationMeasurements of brain-derived neurotrophic factor. Methodological aspects and demographical data.
Trajkovska, V., Marcussen, A. B., Vinberg, M., Hartvig, P., Aznar, S., & Knudsen, G. M. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.03.009 · Cited by 203 · cited 3×
“We have found that BDNF is unstable in frozen samples stored at 280uC as previously raised by other authors who showed that serum BDNF is rapidly degraded with storage at 220uC [20].”
BackgroundMethodResultLow brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients
Ciammola, A., Sassone, J., Cannella, M., Calza, S., Poletti, B., Frati, L., Squitieri, F., & Silani, V. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30501 · Cited by 171 · cited 1×
“. Recently, some of the current authors (JS, AC) have reported that serum BDNF was significantly lower in patients with HD than in age-matched healthy subjects”
BackgroundSelf-citationNeurotrophins and schizophrenia
Buckley, P. F., Mahadik, S., Pillai, A., & Terry, A. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.025 · Cited by 166 · cited 1×
“affecting different organs [1,2,3,4,5].”
Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood
Runne, H., Kuhn, A., Wild, E. J., Pratyaksha, W., Kristiansen, M., Isaacs, J. D., Régulier, E., Delorenzi, M., Tabrizi, S. J., & Luthi-Carter, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703652104 · Cited by 140 · cited 3×
“12 genes were confirmed in one independent study [26], but not in a second one [27].”
BackgroundResultSelf-citationMitoma, M., Yoshimura, R., Sugita, A., Umene, W., Hori, H., Nakano, H., Ueda, N., & Nakamura, J. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.11.011 · Cited by 128
Castrén, E., & Rantamäki, T. (2010) · CNS Drugs · doi:10.2165/11530010-000000000-00000 · Cited by 123
CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice
Apostol, B. L., Simmons, D. A., Zuccato, C., Illes, K., Pallos, J., Casale, M., Conforti, P., Ramos, C., Roarke, M., Kathuria, S., et al. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.04.007 · Cited by 83 · cited 3×
“Studies in mouse models of HD indicated that blood BDNF mRNA also gradually diminishes with disease progression [11,12].”
BackgroundSelf-citationEffects of Storage Time and Exogenous Protease Inhibitors on Plasma Protein Levels
Ayache, S., Panelli, M. C., Marincola, F. M., & Stroncek, D. F. (2006) · American Journal of Clinical Pathology · doi:10.1309/3wm7-xj7r-d8bc-lnkx · Cited by 81
Hashimoto, K., Koizumi, H., Nakazato, M., Shimizu, E., & Iyo, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.01.007 · Cited by 80
Katerberg, H., Lochner, C., Cath, D. C., de Jonge, P., Bochdanovits, Z., Moolman‐Smook, J. C., Hemmings, S. M. J., Carey, P. D., Stein, D. J., Sondervan, D., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30930 · Cited by 76 · cited 1×
“affecting different organs [1,2,3,4,5].”
Squitieri, F., Orobello, S., Cannella, M., Martino, T., Romanelli, P., Giovacchini, G., Frati, L., Mansi, L., & Ciarmiello, A. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1103-3 · Cited by 73 · cited 1×
“Recently, some of the current authors (JS, AC) have reported that serum BDNF was significantly lower in patients with HD than in age-matched healthy subjects [13] and other authors reported significantly higher levels in patients treated with riluzole [14].”
ResultYi, J., Liu, Z., Craft, D., O'Mullan, P. J., Ju, G., & Gelfand, C. A. (2008) · Journal of Proteome Research · doi:10.1021/pr800396c · Cited by 57 · cited 1×
“Although proteases are not completely inactivated in plasma samples, our studies and previous studies demonstrate that plasma is intrinsically more stable than serum and therefore, more useful for protein analyses in biomarker studies [28].”
BackgroundConforti, P., Ramos, C., Apostol, B. L., Simmons, D. A., Nguyen, H. P., Rieß, O., Thompson, L. M., Zuccato, C., & Cattaneo, E. F. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.04.012 · Cited by 55 · cited 4×
“Studies in mouse models of HD indicated that blood BDNF mRNA also gradually diminishes with disease progression [11,12].”
BackgroundInfluentialSelf-citationMarullo, M., Zuccato, C., Mariotti, C., Lahiri, N., Tabrizi, S. J., Di Donato, S., & Cattaneo, E. (2010) · Genome Biology · doi:10.1186/gb-2010-11-1-r9 · Cited by 48 · cited 14×
“based on amplification of the expressed Alu repeat (EAR) [24].”
BackgroundMethodInfluentialSelf-citationGene expression changes in blood as a putative biomarker for Huntington's disease
Lovrečić, L., Kastrin, A., Kobal, J., Pirtošek, Z., Krainc, D., & Peterlin, B. (2009) · Movement Disorders · doi:10.1002/mds.22477 · Cited by 34 · cited 2×
“We focused on the annexin A1 (ANXA1) and rho-associated protein kinase-1 (ROCK1) genes, because their expression was upregulated in HD blood and was sensitive to pharmacological treatment [25,26].”
BackgroundThrombin induces broad spectrum proteolysis in human serum samples
O'Mullan, P. J., Craft, D., Yi, J., & Gelfand, C. A. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.003 · Cited by 31 · cited 1×
“The aspect of protein instability is serum is well known to enzymologists and biochemists [29,30].”
BackgroundO’Gorman, M. R. G., Corrochano, V., Roleck, J., Donovan, M., & Pachman, L. M. (1995) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.2.2.205-208.1995 · Cited by 25
Cited by
Mesenchymal Stem Cells for Neurological Disorders
Andrzejewska, A., Dabrowska, S., Lukomska, B., & Janowski, M. (2021) · Advanced Science · doi:10.1002/advs.202002944 · Cited by 359
Numakawa, T., Odaka, H., & Adachi, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113650 · Cited by 353
“Although correlations between serum levels of BDNF and HD have been controversial, a recent report concluded that levels of BDNF mRNA/protein in human blood samples were not suitable for biomarkers of HD [158].”
BackgroundTrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders
Gupta, V., You, Y., Gupta, V., Klistorner, A., & Graham, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510122 · Cited by 258
“It is also susceptible to proteolytic cleavage and does not have a long half life in blood [119].”
BackgroundPolacchini, A., Metelli, G., Francavilla, R., Baj, G., Florean, M., Mascaretti, L. G., & Tongiorgi, E. (2015) · Scientific Reports · doi:10.1038/srep17989 · Cited by 263
Haile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Foulkes, A., Iqbal, S., Mahoney, J. J., De La Garza, R., Charney, D. S., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001119 · Cited by 253
“…240 min r = −0.897, p = 0.002 r = −0.791, p = 0.038 r = −0.944, p = 0.001 r = −0.777, p = 0.023 r = −0.659, p = 0.098 334 C. N. Haile et al. serum BDNF, because of concerns regarding stability and reliability of using serum as an assay medium for BDNF (Fujimura et al., 2002; Zuccato et al., 2011).”
MethodInfluential
Metadata
- Authors
- Zuccato, C., Marullo, M., Vitali, B., Tarditi, A., Mariotti, C., Valenza, M., Lahiri, N., Wild, E. J., Sassone, J., Ciammola, A., Bachoud-Lèvi, A. C., Tabrizi, S. J., Di Donato, S., & Cattaneo, E.
- Affiliations
- University of Milan (IT)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- National Hospital for Neurology and Neurosurgery (GB)
- IRCCS Istituto Auxologico Italiano (IT)
- Corresponding author
- Cattaneo, Elena
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-12
- Volume
- 6
- Issue
- 8
- Pages
- e22966
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3155522
- OpenAlex
- W2053424572
- Cited by
- 138
- References
- 35
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 3 · 2023: 10 · 2022: 7 · 2021: 16 · 2020: 17 · 2019: 10 · 2018: 11 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 10 · 2013: 11 · 2012: 5
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- CHDI Foundation
- National Institute for Health and Care Research (CL-2009-18-005)
- European Commission
- University College London Hospitals NHS Foundation Trust
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- brain-derived neurotrophic factor, Huntington's disease, serum BDNF, plasma BDNF levels, neurodegeneration, measurement variability, disease progression
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antidepressive Agents, Tricyclic, Benzodiazepines, Enzyme-Linked Immunosorbent Assay, Female, France, Humans, Huntington Disease, Italy, London, Male, Middle Aged, RNA, Messenger, Antipsychotic Agents, Neurotransmitter Uptake Inhibitors, Cohort Studies, Gene Expression, Annexins, Brain-Derived Neurotrophic Factor, Reverse Transcriptase Polymerase Chain Reaction, rho-Associated Kinases, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.